by Jacques Lemoisson | Jan 29, 2021
The vaccine was 57 per cent effective in South Africa, where the 501.v2 variant first emerged, compared with 72 per cent in the US and 66 per cent in Latin America. That’s not great even if countries need a bigger number of vaccine producers. Moderna is reducing...
by Jacques Lemoisson | Jan 27, 2021
Germany is considering almost completely halting flights into the country to slow the spread of more infectious strains of the coronavirus, Interior Minister Horst Seehofer said on Tuesday (Jan 26)… I am still short Europe! Share...
by Jacques Lemoisson | Jan 18, 2021
Dr. Erica S. Pan on Sunday recommended providers stop using lot 41L20A of the Moderna vaccine pending completion of an investigation by state officials, Moderna, the U.S. Centers for Disease Control, and the federal Food and Drug Administration. After the Norway who...
by Jacques Lemoisson | Jan 17, 2021
Norway has expressed increasing concern about the safety of the Pfizer Inc. vaccine on elderly people with serious underlying health conditions after raising their estimate of the number who died after receiving inoculations to 29. In addition to the deaths, people...
by Jacques Lemoisson | Jan 15, 2021
Pfizer has confirmed it will temporarily reduce deliveries to Europe of its COVID-19 vaccine while it upgrades production capacity to 2 billion vaccine doses per year… Interesting timing… Share...
by Jacques Lemoisson | Jan 13, 2021
This is not good news. The mistrust is spreading fast and this vaccine was granted 70/75% effective… In addition, the CEO of Sinopharm (the sole labo authorized by Chinese authorities to sell its vaccine) resigned today, for personal reasons… All countries...